Sort   by:  
 Page size 
GenomicsLethal Cytokine Storm Post-mRNA Booster Vaccination
Lethal Cytokine Storm Post-mRNA Booster Vaccination
PRJNA1008117 | ENA
ProteomicsDiscovery of drugs to treat cytokine storm-induced cardiac dysfunction
SARS-CoV2 infection leads to cardiac injury and dysfunction in 20-30% of hospitalized patients and higher rates of mortality in patients with pre-existing cardiovascular disease. Inflammatory factors released as part of the 'cytokine storm' are thought to play a critical role in cardiac dysfunction ...
ORGANISM(S): Homo sapiens (Human) 
2022-02-21 | PXD020994 | Pride
Sars-cov2 Cardiac organoids Cytokine storm Easyphos Phosphoproteomics Covid-19 Heart 
GenomicsHuman cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries
Human cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries
PRJNA1054224 | ENA
GenomicsSPLEVs, a new therapeutic modality for cytokine storm syndromes
SPLEVs, a new therapeutic modality for cytokine storm syndromes
PRJNA1251004 | ENA
UnknownCytokine Storm.
Not available
S-EPMC7727315 | biostudies-literature
UnknownAn inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
Not available
S-EPMC7651249 | biostudies-literature
UnknownCOVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons.
Not available
S-EPMC7204669 | biostudies-literature
UnknownCytokine storm intervention in the early stages of COVID-19 pneumonia.
Not available
S-EPMC7182527 | biostudies-literature
Genomicsena-DATASET-QCMG-21-04-2021-07:35:14:980-1022 - samples
sn-RNAseq profiling of the impact of a cytokine storm model in human cardiac organoids
EGAD00001007533 | EGA
Genomicssn-RNAseq profiling of the impact of a cytokine storm model in human cardiac organoids
We developed conditions to model conditions of diastolic dysfunction caused by inflammatory factors in human cardiac organoids. Our organoid model is based on conditions promoting maturation (Mills et al., PNAS, 2017 and Voges et al., In Revision) and incorporating human pluripotent stem cell derive...
EGAS00001005174 | EGA
Sort   by:  
 Page size